ClinicalTrials.govpublic full text
Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
nasopharyngeal cancinoma (npc), nasopharangeal cancer, adebrelimab, pd-l1 antibody, chemoradiotherapy, capecitabine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836768
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.